Genome biologyMolecular BiologyPeer-reviewed journal article
Recruitment of the m6A/Am demethylase FTO to target RNAs by the telomeric zinc finger protein ZBTB48
Syed Nabeel‐ShahiD, Shuye PuiD, Giovanni L. BurkeiD, Nujhat Ahmed, Ulrich BraunschweigiD, Shaghayegh Farhangmehr, Hyunmin LeeiD, Mingkun WuiD, Zuyao Ni, Hua Tang, Guoqing Zhong, Edyta Marcon, Zhaolei ZhangiD, Benjamin J. BlencoweiD, Jack F. GreenblattiD
Abstract
N6-methyladenosine (m6A), the most abundant internal modification on eukaryotic mRNA, and N6, 2'-O-dimethyladenosine (m6Am), are epitranscriptomic marks that function in multiple aspects of posttranscriptional regulation. Fat mass and obesity-associated protein (FTO) can remove both m6A and m6Am; however, little is known about how FTO achieves its substrate selectivity. Here, we demonstrate that ZBTB48, a C2H2-zinc finger protein that functions in telomere maintenance, associates with FTO and binds both mRNA and the telomere-associated regulatory RNA TERRA to regulate the functional interactions of FTO with target transcripts. Specifically, depletion of ZBTB48 affects targeting of FTO to sites of m6A/m6Am modification, changes cellular m6A/m6Am levels and, consequently, alters decay rates of target RNAs. ZBTB48 ablation also accelerates growth of HCT-116 colorectal cancer cells and modulates FTO- dependent regulation of Metastasis-associated protein 1 (MTA1) transcripts by controlling the binding to MTA1 mRNA of the m6A reader IGF2BP2. Our findings thus uncover a previously unknown mechanism of posttranscriptional regulation in which ZBTB48 co-ordinates RNA- binding of the m6A/m6Am demethylase FTO to control expression of its target RNAs.
- organism: human
- assay: metagenomics
- research focus: differential expression
- research focus: cell type annotation
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: statistical model
- approach: experimental assay
- Citations
- 17
- FWCI
- 2.31
- Field percentile
- top 10%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- FTO does not function as an m6A eraser in AML: a reassessment using direct RNA nanopore sequencing
Louise V. B. Nicholson, Catarina Guimarães‐Teixeira, … Samie R. Jaffrey·bioRxiv·Oct 22, 2025
- Oncogenic functions of the m6A demethylase FTO in breast cancer cells involving translational upregulation of C/EBPβ-LIP
H. R. Zuidhof, C. Müller, … C. F. Calkhoven·bioRxiv·Sep 21, 2023
- RNA demethylase FTO uses conserved aromatic residues to recognize the mRNA 5' cap and promote efficient m6Am demethylation
Brittany A. Shimanski, Juan F. Marín, … Jeffrey S. Mugridge·Journal of Biological ChemistryPeer-reviewed·Sep 17, 2026
- FTO separation-of-function mutations alter m6A versus m6Am demethylation selectivity on RNA
Kasun Dilshan Abeyrathne Eluwawalage, Brittany A. Shimanski, … Jeffrey S. Mugridge·bioRxiv·May 19, 2026
- Single-molecule m6A profiling reveals position-dependent mRNA regulation and non-canonical roles for Ythdf2 in early embryogenesis
Sarah A. Alshawi, Anna Delgado-Tejedor, … Jean-Denis Beaudoin·bioRxiv·Jul 6, 2026
- FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell
S. RELIER, J. RIPOLL, … A. DAVID·Nature CommunicationsPeer-reviewed·Mar 19, 2021